ISAF Hybrid 2023
BackImpact of Dupilumab Treatment on Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Asthma
Friday 06 Oct, 09:33 AM -
09:44 AM Europe/Rome
Sala Germania
Oral Presentations